Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2023-02-07
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.6bn
reported value
+23.8% vs Q3 2022
44positions
66.4%in top 10
7 new
9 added
5 reduced
6 sold out
vs Q3 2022
Holdings, Q4 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| HILLEVAX INC COM | $163.3m10.15% | Unchanged |
| IMAGO BIOSCIENCES INC COM | $143.3m8.91% | Added +1.0m |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $128.5m7.99% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $113.9m7.08% | Added +80.0k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $101.8m6.33% | New |
| SYNDAX PHARMACEUTICALS INC SNDX | $94.4m5.87% | Added +296.0k |
| PHATHOM PHARMACEUTICALS INC PHAT | $94.3m5.86% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $79.2m4.92% | Reduced -18.7k |
| MIRUM PHARMACEUTICALS INC MIRM | $75.3m4.68% | Added +32.3k |
| VERONA PHARMA PLC VRNA | $73.6m4.57% | Added +716.2k |
| VAXCYTE INC PCVX | $67.0m4.17% | Reduced -150.0k |
| RHYTHM PHARMACEUTICALS INC RYTM | $55.2m3.43% | Unchanged |
| ALLAKOS INC ALLKG | $40.3m2.51% | Unchanged |
| ANAPTYSBIO INC ANAB | $27.9m1.73% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $26.2m1.63% | Unchanged |
| CRINETICS PHARMACEUTICALS IN CRNX | $25.9m1.61% | Unchanged |
| REPLIMUNE GROUP INC REPL | $25.3m1.58% | Added +125.3k |
| COGENT BIOSCIENCES INC COGT | $24.4m1.52% | Added +35.0k |
| ALPINE IMMUNE SCIENCES INC NVLS | $21.9m1.36% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $21.9m1.36% | Added +1.7m |
| GRITSTONE BIO INC GRTS | $17.8m1.11% | Reduced -75.0k |
| SUTRO BIOPHARMA INC COM | $14.4m0.89% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $13.6m0.85% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $13.4m0.84% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $12.9m0.80% | Added +1.3m |
| CEREVEL THERAPEUTICS HLDNG I CERE | $12.4m0.77% | Unchanged |
| MERUS N V MRUS | $11.5m0.72% | Unchanged |
| VECTIVBIO HLDG AG ORD SHS | $11.5m0.71% | New |
| AVIDITY BIOSCIENCES INC RNA | $11.1m0.69% | New |
| IMMUNOVANT INC IMVT | $10.4m0.65% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $10.1m0.63% | Unchanged |
| BLUEBIRD BIO INC COM | $10.0m0.62% | Unchanged |
| ARVINAS INC ARVN | $9.8m0.61% | Unchanged |
| PROTHENA CORP PLC PRTA | $7.7m0.48% | New |
| AUTOLUS THERAPEUTICS PLC AUTL | $7.1m0.44% | Unchanged |
| INTELLIA THERAPEUTICS INC NTLA | $7.1m0.44% | Unchanged |
| THESEUS PHARMACEUTICALS INC COM | $7.0m0.43% | New |
| PASSAGE BIO INC COM | $5.2m0.32% | Unchanged |
| ZYMEWORKS INC ZYME | $4.8m0.30% | New |
| ACLARIS THERAPEUTICS INC ACRS | $4.6m0.28% | Reduced -118.1k |
| ESSA PHARMA INC EPI | $1.5m0.09% | Reduced -87.8k |
| APTINYX INC COM | $537.3k0.03% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $434.3k0.03% | New |
| NABRIVA THERAPEUTICS PLC NBRVF | $32.2k0.00% | Unchanged |
Sold out since Q3 2022
| Security | Value then |
|---|---|
| TRICIDA INC TCDA | $26.7m2.5m shares |
| FRAZIER LIFESCIENCES ACQU CO | $15.2m1.5m shares |
| GRACELL BIOTECHNOLOGIES INC | $9.3m2.9m shares |
| MACROGENICS INC MGNX | $2.4m701.6k shares |
| PARDES BIOSCIENCES INC | $1.6m845.6k shares |
| MOLECULAR TEMPLATES INC | $1.0m1.4m shares |